201 related articles for article (PubMed ID: 35085104)
1. Eltrombopag inhibits TET dioxygenase to contribute to hematopoietic stem cell expansion in aplastic anemia.
Guan Y; Hasipek M; Jiang D; Tiwari AD; Grabowski DR; Pagliuca S; Kongkiatkamon S; Patel B; Singh S; Parker Y; LaFramboise T; Lindner D; Sekeres MA; Mian OY; Saunthararajah Y; Maciejewski JP; Jha BK
J Clin Invest; 2022 Feb; 132(4):. PubMed ID: 35085104
[TBL] [Abstract][Full Text] [Related]
2. Eltrombopag, a thrombopoietin receptor agonist, enhances human umbilical cord blood hematopoietic stem/primitive progenitor cell expansion and promotes multi-lineage hematopoiesis.
Sun H; Tsai Y; Nowak I; Liesveld J; Chen Y
Stem Cell Res; 2012 Sep; 9(2):77-86. PubMed ID: 22683680
[TBL] [Abstract][Full Text] [Related]
3. Eltrombopag preferentially expands haematopoietic multipotent progenitors in human aplastic anaemia.
Quintino de Oliveira B; Catto LFB; Santana BAA; Tellechea MF; Scheucher PS; Scheinberg P; Calado RT
Br J Haematol; 2021 Apr; 193(2):410-414. PubMed ID: 33216370
[TBL] [Abstract][Full Text] [Related]
4. Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug.
Desmond R; Townsley DM; Dumitriu B; Olnes MJ; Scheinberg P; Bevans M; Parikh AR; Broder K; Calvo KR; Wu CO; Young NS; Dunbar CE
Blood; 2014 Mar; 123(12):1818-25. PubMed ID: 24345753
[TBL] [Abstract][Full Text] [Related]
5. Eltrombopag for the treatment of aplastic anemia: current perspectives.
Lum SH; Grainger JD
Drug Des Devel Ther; 2016; 10():2833-2843. PubMed ID: 27695288
[TBL] [Abstract][Full Text] [Related]
6. Trilineage Hematopoiesis Induced by Low-dose Eltrombopag in a Patient With Fanconi Anemia can be Used as a Bridge to Hematopoietic Stem Cell Transplant.
Gupta A; Palassery R; Meyerson H; Ahuja S; Matloub Y
J Pediatr Hematol Oncol; 2019 Apr; 41(3):229-232. PubMed ID: 29668547
[TBL] [Abstract][Full Text] [Related]
7. Eltrombopag Improves Erythroid Differentiation in a Human Induced Pluripotent Stem Cell Model of Diamond Blackfan Anemia.
Qanash H; Li Y; Smith RH; Linask K; Young-Baird S; Hakami W; Keyvanfar K; Choy JS; Zou J; Larochelle A
Cells; 2021 Mar; 10(4):. PubMed ID: 33810313
[TBL] [Abstract][Full Text] [Related]
8. Eltrombopag for treatment of thrombocytopenia-associated disorders.
Merli P; Strocchio L; Vinti L; Palumbo G; Locatelli F
Expert Opin Pharmacother; 2015; 16(14):2243-56. PubMed ID: 26364898
[TBL] [Abstract][Full Text] [Related]
9. Thrombopoietin receptor-independent stimulation of hematopoietic stem cells by eltrombopag.
Kao YR; Chen J; Narayanagari SR; Todorova TI; Aivalioti MM; Ferreira M; Ramos PM; Pallaud C; Mantzaris I; Shastri A; Bussel JB; Verma A; Steidl U; Will B
Sci Transl Med; 2018 Sep; 10(458):. PubMed ID: 30209246
[TBL] [Abstract][Full Text] [Related]
10. Eltrombopag and improved hematopoiesis in refractory aplastic anemia.
Olnes MJ; Scheinberg P; Calvo KR; Desmond R; Tang Y; Dumitriu B; Parikh AR; Soto S; Biancotto A; Feng X; Lozier J; Wu CO; Young NS; Dunbar CE
N Engl J Med; 2012 Jul; 367(1):11-9. PubMed ID: 22762314
[TBL] [Abstract][Full Text] [Related]
11. The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation.
Vogel JU; Schmidt S; Schmidt D; Rothweiler F; Koch B; Baer P; Rabenau H; Michel D; Stamminger T; Michaelis M; Cinatl J
Cells; 2019 Dec; 9(1):. PubMed ID: 31861948
[TBL] [Abstract][Full Text] [Related]
12. Eltrombopag: a review of its use in patients with severe aplastic anaemia.
McCormack PL
Drugs; 2015 Apr; 75(5):525-31. PubMed ID: 25700916
[TBL] [Abstract][Full Text] [Related]
13. Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia.
Townsley DM; Scheinberg P; Winkler T; Desmond R; Dumitriu B; Rios O; Weinstein B; Valdez J; Lotter J; Feng X; Desierto M; Leuva H; Bevans M; Wu C; Larochelle A; Calvo KR; Dunbar CE; Young NS
N Engl J Med; 2017 Apr; 376(16):1540-1550. PubMed ID: 28423296
[TBL] [Abstract][Full Text] [Related]
14. Eltrombopag mobilizes iron in patients with aplastic anemia.
Zhao Z; Sun Q; Sokoll LJ; Streiff M; Cheng Z; Grasmeder S; Townsley DM; Young NS; Dunbar CE; Winkler T
Blood; 2018 May; 131(21):2399-2402. PubMed ID: 29632023
[No Abstract] [Full Text] [Related]
15. Eltrombopag promotes DNA repair in human hematopoietic stem and progenitor cells.
Guenther KL; Cheruku PS; Cash A; Smith RH; Alvarado LJ; Burkett S; Townsley DM; Winkler T; Larochelle A
Exp Hematol; 2019 May; 73():1-6.e6. PubMed ID: 30986494
[TBL] [Abstract][Full Text] [Related]
16. A Therapeutic Strategy for Preferential Targeting of TET2 Mutant and TET-dioxygenase Deficient Cells in Myeloid Neoplasms.
Guan Y; Tiwari AD; Phillips JG; Hasipek M; Grabowski DR; Pagliuca S; Gopal P; Kerr CM; Adema V; Radivoyevitch T; Parker Y; Lindner DJ; Meggendorfer M; Abazeed M; Sekeres MA; Mian OY; Haferlach T; Maciejewski JP; Jha BK
Blood Cancer Discov; 2021 Mar; 2(2):146-161. PubMed ID: 33681816
[No Abstract] [Full Text] [Related]
17. Eltrombopag inhibits the proliferation of Ewing sarcoma cells via iron chelation and impaired DNA replication.
Waters T; Goss KL; Koppenhafer SL; Terry WW; Gordon DJ
BMC Cancer; 2020 Nov; 20(1):1171. PubMed ID: 33256675
[TBL] [Abstract][Full Text] [Related]
18. Successful eltrombopag treatment of severe refractory thrombocytopenia in chronic myelomonocytic leukemia: Two cases reports: A CARE-compliant article.
Gao Y; Gong M; Zhang C; Kong X; Ma Y
Medicine (Baltimore); 2017 Oct; 96(43):e8337. PubMed ID: 29069007
[TBL] [Abstract][Full Text] [Related]
19. Effect of the nonpeptide thrombopoietin receptor agonist Eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome.
Will B; Kawahara M; Luciano JP; Bruns I; Parekh S; Erickson-Miller CL; Aivado MA; Verma A; Steidl U
Blood; 2009 Oct; 114(18):3899-908. PubMed ID: 19710504
[TBL] [Abstract][Full Text] [Related]
20. Upfront eltrombopag monotherapy induces stable hematologic remission in pediatric patients with nonsevere idiopathic aplastic anemia.
Geng W; Kearney S; Nelson S
Pediatr Blood Cancer; 2018 Oct; 65(10):e27290. PubMed ID: 29932285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
